The mission of Acepodia, Inc. is to develop safe, effective, and affordable immunotherapeutic medicines targeting diseases with significant unmet medical needs, with our current primary focus in oncology. Our collaboration ranges from academies, hospitals to industries.
Pioneering in thriving
Acepodia is committed to immunotherapeutic strategies against oncology – expanding our research, clinical development, and manufacturing capabilities. Acepodia currently has a broad pipeline portfolio, each targeting a different type of cancer.